CTOs on the Move

Encore Dermatology

www.encorederm.com

 
Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully integrated dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.encorederm.com
  • 5 Great Valley Pkwy Suite 200
    Malvern, PA USA 19355
  • Phone: 844.848.6543

Executives

Name Title Contact Details

Funding

Encore Dermatology raised $20M on 04/08/2019

Similar Companies

Horizon Therapeutics

At Horizon Therapeutics, we believe science and compassion must work together to transform lives. We are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. For us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.

Sigmapharm

Sigmapharm Laboratories LLC

Afaxys

Afaxys mission is to deliver products and services to public health providers affordably, reliably and with an unwavering focus on customer service.

Canderm Pharma

Canderm Pharma, Inc. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KCR

KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people.